Schroder Investment Management Group Emergent Bio Solutions Inc. Transaction History

Schroder Investment Management Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $45,599 - $65,275	-1,250 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $41,387 - $68,762	1,250 New	1,250 $54,000
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $62,587 - $82,562	-1,250 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $225,491 - $327,371	-2,615 Reduced 67.66%	1,250 $116,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $3.63 Million - $5.11 Million	-45,836 Reduced 92.22%	3,865 $346,000
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $4.07 Million - $6.71 Million	49,701 New	49,701 $4.98 Million
Q2 2019 Aug 08, 2019	SELL	$39.92 - $53.86 $380,796 - $513,770	-9,539 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $7.12 Million - $9.77 Million	-147,700 Reduced 93.93%	9,539 $482,000
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $8.75 Million - $11.5 Million	157,239 New	157,239 $9.32 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.